Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Stereotaxis Inc. STXS

Healthcare  —  Medical Instruments & Supplies
1.30 0.01 0.78% as of 25 Sep
Market cap
$133.3M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Stereotaxis Inc. (STXS) Business Profile

Updated before January 2025

Company Overview

Stereotaxis Inc. (STXS) is a pioneering medical technology company specializing in robotic systems for minimally invasive surgery. Founded in 1990 and headquartered in St. Louis, Missouri, Stereotaxis has established itself as a leader in the field of robotic-assisted interventions, particularly in the treatment of cardiac arrhythmias. The company was founded with the vision of leveraging advanced robotics and magnetic navigation to improve the precision, safety, and efficacy of complex medical procedures. Over the years, Stereotaxis has developed a robust portfolio of innovative technologies that have been adopted by leading hospitals and healthcare institutions worldwide.

The company is led by a team of seasoned executives with extensive experience in the medical technology and healthcare sectors. David L. Fischel serves as the Chairman and Chief Executive Officer, bringing a strong background in strategic leadership and innovation. Under his guidance, Stereotaxis has continued to expand its product offerings and global footprint, solidifying its position as a key player in the medical robotics industry.

Core Business Segments

Stereotaxis operates primarily in the field of robotic-assisted medical technologies, with a focus on the following core business segments:

1. Robotic Magnetic Navigation Systems

Stereotaxis is best known for its Niobe® Magnetic Navigation System, a state-of-the-art platform that enables physicians to perform complex cardiac procedures with unparalleled precision. The system uses magnetic fields to guide catheters and other devices through the intricate pathways of the heart, reducing the risk of complications and improving patient outcomes. Key features of the Niobe® system include real-time imaging, remote control capabilities, and compatibility with a wide range of medical devices.

2. Imaging and Mapping Solutions

To complement its robotic systems, Stereotaxis offers advanced imaging and mapping technologies that enhance the accuracy and efficiency of medical procedures. The Odyssey® Solution is a comprehensive platform that integrates real-time imaging, data management, and remote collaboration tools, enabling physicians to make informed decisions during complex interventions. The system also supports remote case review and consultation, fostering collaboration among medical professionals.

3. Disposable Interventional Devices

Stereotaxis provides a range of disposable interventional devices designed for use with its robotic systems. These include magnetic catheters, guidewires, and other accessories that are essential for performing minimally invasive procedures. The company collaborates with leading medical device manufacturers to ensure compatibility and high-quality standards.

4. Service and Support

In addition to its product offerings, Stereotaxis provides comprehensive service and support to its customers. This includes installation, training, maintenance, and technical support to ensure the optimal performance of its systems. The company also offers software updates and upgrades to keep its technologies at the forefront of innovation.

Business Model

Stereotaxis operates on a hybrid business model that combines product sales, recurring revenue from disposable devices, and service contracts. The company generates revenue through the sale of its robotic systems, which are typically purchased by hospitals and healthcare institutions. These systems serve as a platform for ongoing revenue streams from the sale of disposable devices and accessories used in each procedure.

Additionally, Stereotaxis offers service contracts that provide customers with access to maintenance, technical support, and software updates. This recurring revenue model ensures a steady income stream while fostering long-term relationships with customers. By integrating its products and services, Stereotaxis delivers a comprehensive solution that addresses the needs of healthcare providers and patients alike.

Strategic Direction

Stereotaxis is committed to advancing the field of robotic-assisted medical technologies through continuous innovation and strategic growth initiatives. The company’s future plans include:

  • Expanding Product Portfolio: Stereotaxis is actively developing new robotic systems and interventional devices to address a broader range of medical conditions. This includes exploring opportunities in neurology, oncology, and other specialties.
  • Global Market Expansion: The company aims to increase its presence in international markets, particularly in regions with growing demand for advanced medical technologies. This includes establishing partnerships with local distributors and healthcare providers.
  • Sustainability Goals: Stereotaxis is dedicated to promoting sustainability in its operations and product development. This includes reducing waste, optimizing energy efficiency, and adopting environmentally friendly manufacturing practices.
  • Enhancing Remote Capabilities: Building on the success of its Odyssey® Solution, Stereotaxis plans to further develop remote collaboration and telemedicine capabilities, enabling physicians to perform procedures and consultations from virtually anywhere.

Competitive Landscape

Stereotaxis operates in a highly competitive market, facing competition from both established players and emerging startups in the medical technology sector. Key competitors include:

  • Intuitive Surgical: A leader in robotic-assisted surgery, known for its da Vinci® Surgical System.
  • Medtronic: A global healthcare solutions company offering a wide range of medical devices and technologies.
  • Biosense Webster (a Johnson & Johnson company): Specializes in electrophysiology and cardiac ablation technologies.
  • Auris Health (a subsidiary of Johnson & Johnson): Focuses on robotic endoscopy and minimally invasive procedures.
  • Corindus Vascular Robotics (a Siemens Healthineers company): Develops robotic systems for vascular interventions.

Despite the competitive landscape, Stereotaxis differentiates itself through its unique magnetic navigation technology and focus on cardiac interventions.

Risk Factors

Stereotaxis faces several risks that could impact its business operations and financial performance, including:

  • Market Dependence: The company relies heavily on the adoption of its robotic systems and disposable devices. Any decline in demand could adversely affect revenue.
  • Regulatory Challenges: As a medical technology company, Stereotaxis is subject to stringent regulatory requirements. Delays or failures in obtaining approvals could hinder product launches.
  • Supply Chain Disruptions: The company depends on a global supply chain for the production of its systems and devices. Disruptions due to geopolitical tensions, natural disasters, or pandemics could impact operations.
  • Competition: Intense competition from larger, well-funded companies poses a risk to Stereotaxis’s market share and pricing power.
  • Technological Obsolescence: Rapid advancements in medical technology could render Stereotaxis’s products obsolete if the company fails to innovate.

Recent Developments

Stereotaxis has made significant strides in recent years, including:

  • Launch of Genesis RMN® System: The company introduced its next-generation robotic magnetic navigation system, which offers enhanced performance, reliability, and ease of use.
  • Partnerships and Collaborations: Stereotaxis has entered into strategic partnerships with leading medical institutions and device manufacturers to expand its product offerings and market reach.
  • Remote Capabilities: The company has enhanced its Odyssey® Solution to support remote case review and collaboration, addressing the growing demand for telemedicine solutions.
  • Global Expansion: Stereotaxis has established new distribution agreements in key international markets, including Asia and Europe.

Investment Considerations

Strengths:

  • Proven track record of innovation in robotic-assisted medical technologies.
  • Strong recurring revenue model from disposable devices and service contracts.
  • Growing global presence and market opportunities.
  • Focus on sustainability and remote capabilities.

Risks:

  • Dependence on a niche market segment.
  • Exposure to regulatory and supply chain risks.
  • Intense competition from larger players.

Conclusion

Stereotaxis Inc. is a trailblazer in the field of robotic-assisted medical technologies, with a strong focus on improving patient outcomes through innovation and precision. The company’s unique magnetic navigation systems and complementary product offerings have positioned it as a leader in the treatment of cardiac arrhythmias. While Stereotaxis faces challenges such as competition and regulatory risks, its commitment to innovation, global expansion, and sustainability provides a solid foundation for future growth. As the demand for advanced medical technologies continues to rise, Stereotaxis is well-positioned to capitalize on emerging opportunities and maintain its leadership in the industry.